The moment Moderna posted this tweet,They shut down all comments on the X feed they are using… Safe and Effective?
We announced today that the U.S. FDA has approved mNEXSPIKEยฎ, a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomesโฆ pic.twitter.com/RJ1CezICKZ
— Moderna (@moderna_tx) May 31, 2025
When we look at the inserts,You know why….
The document breaksdown the adverse events by 3 age groups: 12-17, 18-64, & 65+. They compare their 28 day follow-up to the prior C-19 jabs which followed up for 8.8mo’s.
They admit 2.7% of their trial participants experienced serious adverse events.
[0.1% more than the prior vaccines did]
